Overview

A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to explore the effect of multiple oral doses of itraconazole on the pharmacokinetics of a single oral dose of ASP1707 in healthy female subjects. This study will also evaluate the safety and tolerability of a single oral dose of ASP1707 alone and in combination with itraconazole.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Europe B.V.
Treatments:
Hydroxyitraconazole
Itraconazole